or Try an Advanced Search...

    Technical Analysis for NRXS - Neuraxis, Inc.

    Grade Last Price % Change Price Change
    B 3.11 -2.50% -0.08
    NRXS closed down 1.85 percent on Wednesday, November 20, 2024, on 1.4 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical NRXS trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish -2.50%
    Doji - Bullish? Reversal -2.50%
    Wide Bands Range Expansion -2.50%
    Pocket Pivot Bullish Swing Setup -4.30%
    NR7 Range Contraction -4.30%
    Narrow Range Bar Range Contraction -4.30%
    Wide Bands Range Expansion -4.30%
    200 DMA Support Bullish 0.33%
    Wide Bands Range Expansion 0.33%
    Bearish Engulfing Bearish -1.27%
    Older End-of-Day Signals for NRXS ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 4 hours ago
    200 DMA Support 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NRXS Chart by TradingView
    Basic chart:

    Profile

    NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. NeurAxis, Inc. was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is based in Versailles, Indiana.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Neuromodulation Neurophysiology Neurotechnology Abdominal Pain Irritable Bowel Syndrome Neuropsychology

    Is NRXS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript
    Nov 15 NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage
    Nov 12 NeurAxis reports Q3 results
    Nov 12 NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 5 NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
    Nov 4 NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
    Oct 29 NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024
    Oct 22 NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation
    Sep 25 Zacks Initiates Coverage of NeurAxis With Neutral Recommendation
    See more NRXS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.89
    52 Week Low 2.0
    Average Volume 14,232
    200-Day Moving Average 3.07
    50-Day Moving Average 2.92
    20-Day Moving Average 2.86
    10-Day Moving Average 2.97
    Average True Range 0.35
    RSI (14) 59.02
    ADX 29.6
    +DI 23.17
    -DI 13.95
    Chandelier Exit (Long, 3 ATRs) 2.74
    Chandelier Exit (Short, 3 ATRs) 3.09
    Upper Bollinger Bands 3.42
    Lower Bollinger Band 2.30
    Percent B (%b) 0.8
    BandWidth 39.34
    MACD Line 0.08
    MACD Signal Line 0.01
    MACD Histogram 0.0679
    Fundamentals Value
    Market Cap 16.87 Million
    Num Shares 5.29 Million
    EPS -1.85
    Price-to-Earnings (P/E) Ratio -1.72
    Price-to-Sales 7.15
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.58
    Resistance 3 (R3) 3.57 3.43 3.52
    Resistance 2 (R2) 3.43 3.33 3.44 3.49
    Resistance 1 (R1) 3.31 3.27 3.37 3.32 3.47
    Pivot Point 3.17 3.17 3.20 3.18 3.17
    Support 1 (S1) 3.05 3.07 3.11 3.06 2.91
    Support 2 (S2) 2.91 3.01 2.92 2.89
    Support 3 (S3) 2.79 2.91 2.87
    Support 4 (S4) 2.80